iDose® TR

iDose® TR is a New Treatment Option to Reduce Eye Pressure in Patients with Ocular Hypertension and Open-Angle Glaucoma

Glaucoma is one of the leading causes of permanent blindness in the world. It is an irreversible disease that damages the optic nerve and is often associated with increased eye pressure. Left untreated, glaucoma can cause blindness.

Northwest Eye Surgeons is proud to offer a new option for lowering eye pressure caused by some types of Glaucoma: iDose® TR. iDose TR is a new, FDA approved treatment that is designed to continuously release medication to lower your eye pressure directly inside your eye, where it’s most needed. iDose TR is placed directly in the eye through a tiny incision that is smaller than the one used for cataract surgery.

For most people, the procedure is painless and performed in an outpatient setting. iDose TR typically has a fast recovery time – you go home and rest after the procedure and can usually resume your regular activities in a day or two. Best of all, with iDose TR, you get the prescription-strength medication your eyes need without the challenges or inconvenience of having to use daily drops. In a clinical study, 8 out of 10 patients did not need prescription eye drops 12 months after iDose TR administration.